Top

Published in:

01-12-2008 | Invited Commentary

Liver Resection for Intrahepatic Cholangiocellular Carcinoma: When is it Worthwhile?

Authors: C. Pulitano, R. W. Parks

Published in: World Journal of Surgery | Issue 12/2008

Excerpt

Intrahepatic cholangiocarcinoma (ICC) accounts for 10–20% of primary liver malignancies, with an increasing incidence in western countries during recent years. In general, prognosis is poor, with a reported median survival of less than 9 months after diagnosis in the majority of patients with unresectable disease [1]. Aggressive resection is the mainstay of surgical treatment for ICC, offering patients the best chance for prolonged survival [2, 3]. However, comparison of survival data in the literature is difficult due to the often inhomogeneous selection criteria and the small number of cases. …

Wood R, Brewster DH, Fraser LA et al (2003) Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 39(14):2087–2092PubMedCrossRef

DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762PubMedCrossRef

Konstadoulakis MM, Roayaie S, Gomatos IP et al (2008) Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 143(3):366–374PubMedCrossRef

Nakagohri T, Kinoshita T, Konishi M et al (2008) Surgical out come and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg. doi:10.1007/s00268-008-9778-3 [Epub ahead of print]

Khan SA, Davidson BR, Goldin R et al (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):1–9

Title: Liver Resection for Intrahepatic Cholangiocellular Carcinoma: When is it Worthwhile?
Authors: C. Pulitano
R. W. Parks
Publication date: 01-12-2008
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 12/2008
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-008-9730-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Liver Resection for Intrahepatic Cholangiocellular Carcinoma: When is it Worthwhile?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2008

Acknowledgements

Oncoplastic Breast Surgery: A Global Perspective on Practice, Availability, and Training

ISS-SIC Donations

Implementation of an Ultra-short-stay Program After Breast Cancer Surgery in Four Hospitals: Perceived Barriers and Facilitators

Feasibility Study of Safe Breast Conservation in Large and Locally Advanced Cancers with Use of Radiopaque Markers to Mark Pre-Neoadjuvant Chemotherapy Tumor Margins

Long-Term Changes in Parathyroid Function After Subtotal Thyroidectomy for Graves’ Disease